“We in the Senate remain open to the ideas of the House, and we will enter bicameral talks with the end-goal of making the best bill for our people,” said Senator Manuel “Mar” Roxas II.
Roxas conceded that the sponsors of a similar bill in the House correctly anticipated that big drug companies could manipulate and prevent drugstores from selling imported cheaper medicines.
He said the use of price controls could come in if market competition from cheaper medicines from abroad and generic drugs do not work and make medicines affordable to the public.
“I’m very attracted to that idea (of a must carry provision) because these medicines may come in but if they’re stacked in a warehouse, there won’t be any change in prices,” he said.
Read more...
